ADMA Biologics, Inc. (ADMA)
13.56
-0.06
(-0.48%)
USD |
NASDAQ |
Nov 18, 16:00
13.50
-0.06
(-0.48%)
After-Hours: 19:17
ADMA Biologics Total Return Level : 13.63 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 13.63 |
| November 16, 2026 | 13.47 |
| November 13, 2026 | 13.68 |
| November 12, 2026 | 13.24 |
| November 11, 2026 | 13.19 |
| November 10, 2026 | 12.67 |
| November 09, 2026 | 12.79 |
| November 06, 2026 | 12.73 |
| November 05, 2026 | 13.21 |
| November 04, 2026 | 10.48 |
| November 03, 2026 | 11.11 |
| November 02, 2026 | 11.06 |
| October 30, 2026 | 11.41 |
| October 29, 2026 | 11.75 |
| October 28, 2026 | 11.28 |
| October 27, 2026 | 11.17 |
| October 26, 2026 | 11.06 |
| October 23, 2026 | 10.68 |
| October 22, 2026 | 10.95 |
| October 21, 2026 | 11.01 |
| October 20, 2026 | 11.23 |
| October 19, 2026 | 11.07 |
| October 16, 2026 | 10.68 |
| October 15, 2026 | 10.73 |
| October 14, 2026 | 10.34 |
| Date | Value |
|---|---|
| October 13, 2026 | 10.31 |
| October 12, 2026 | 10.18 |
| October 09, 2026 | 10.36 |
| October 08, 2026 | 10.33 |
| October 07, 2026 | 10.14 |
| October 06, 2026 | 10.18 |
| October 05, 2026 | 10.11 |
| October 02, 2026 | 9.72 |
| October 01, 2026 | 9.93 |
| September 30, 2026 | 10.03 |
| September 29, 2026 | 9.96 |
| September 28, 2026 | 10.12 |
| September 25, 2026 | 9.38 |
| September 24, 2026 | 9.52 |
| September 23, 2026 | 9.70 |
| September 22, 2026 | 9.81 |
| September 21, 2026 | 9.505 |
| September 18, 2026 | 9.11 |
| September 17, 2026 | 8.95 |
| September 16, 2026 | 8.90 |
| September 15, 2026 | 8.61 |
| September 14, 2026 | 9.14 |
| September 11, 2026 | 9.23 |
| September 10, 2026 | 9.39 |
| September 09, 2026 | 9.45 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.32 |
| BioMarin Pharmaceutical, Inc. | 58.51 |
| Nektar Therapeutics | 35.91 |
| Rhythm Pharmaceuticals, Inc. | 116.61 |
| Arcutis Biotherapeutics, Inc. | 27.33 |